Glenmark Life Sciences Limited (IN:ALIVUS)
:ALIVUS
Want to see IN:ALIVUS full AI Analyst Report?
Summary of all the Indicators
Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Glenmark Life Sciences Limited’s (ALIVUS) Moving Averages Convergence Divergence (MACD) indicator is 0.43, suggesting Glenmark Life Sciences Limited is a Sell.
Glenmark Life Sciences Limited’s (ALIVUS) 20-Day exponential moving average is 1048.21, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Buy.
Glenmark Life Sciences Limited’s (ALIVUS) 50-Day exponential moving average is 1037.68, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Buy.
Glenmark Life Sciences Limited (ALIVUS) Pivot Points
Classic
1,033.10
1,040.10
1,049.95
1,056.95
1,066.80
1,073.80
1,083.65
Fibonacci
1,040.10
1,046.54
1,050.51
1,056.95
1,063.39
1,067.36
1,073.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Glenmark Life Sciences Limited (ALIVUS) Moving Averages
MA5
1,054.40Buy
1,055.60Buy
MA10
1,040.62Buy
1,049.19Buy
MA20
1,045.25Buy
1,048.21Buy
MA50
1,056.73Buy
1,037.68Buy
MA100
994.10Buy
1,009.97Buy
MA200
955.39Buy
983.48Buy
Glenmark Life Sciences Limited’s (ALIVUS) 10-Day exponential moving average is 1049.19, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Buy.
Glenmark Life Sciences Limited’s (ALIVUS) 100-Day exponential moving average is 1009.97, while Glenmark Life Sciences Limited’s (ALIVUS) share price is ₹920.8, making it a Buy.
Glenmark Life Sciences Limited’s (ALIVUS) stock price is ₹920.8 and Glenmark Life Sciences Limited’s (ALIVUS) 50-day simple moving average is 1056.73, creating a Buy signal.
Glenmark Life Sciences Limited’s (ALIVUS) stock price is ₹920.8 and Glenmark Life Sciences Limited’s (ALIVUS) 100-day simple moving average is 994.10, creating a Buy signal.
Glenmark Life Sciences Limited’s (ALIVUS) stock price is ₹920.8 and Glenmark Life Sciences Limited’s (ALIVUS) 200-day simple moving average is 955.39, creating a Buy signal.
Glenmark Life Sciences Limited (ALIVUS) Technical Indicators
RSI (14)
56.47
Neutral
STOCH (9,6)
73.42
Neutral
STOCHRSI (14)
67.56
Neutral
MACD (12,26)
0.43
Sell
ADX (14)
11.02
Buy
Williams %R
-18.10
Sell
CCI (14)
101.75
Sell
ATR (14)
33.86
-
Ultimate Oscillator
37.48
Neutral
ROC
1.96
Buy
Glenmark Life Sciences Limited’s (ALIVUS) Relative Strength Index (RSI) is 56.47, creating a Neutral signal.
Glenmark Life Sciences Limited’s (ALIVUS) Trend Strength Indicator (ADX) is 11.02, creating a Buy signal.
Glenmark Life Sciences Limited’s (ALIVUS) Commodity Channel Index (CCI) is 101.75, creating a Sell signal.
Glenmark Life Sciences Limited’s (ALIVUS) Price Rate of Change (ROC) is 1.96, creating a Buy signal.
FAQ
Is ALIVUS a Buy, Hold, or Sell?
Based on ALIVUS’s technical indicators, ALIVUS is a Strong Buy.
What is ALIVUS’s RSI (14)?
ALIVUS’s RSI (14) is 56.47, which suggests ALIVUS is a Neutral.
What is ALIVUS’s MACD?
ALIVUS’s MACD is 0.43, which suggests ALIVUS is a Sell.
What is ALIVUS’s 5-day moving average?
ALIVUS’s 5-day moving average is 1054.40, which suggests ALIVUS is a Buy.
What is ALIVUS’s 20-day moving average?
ALIVUS 20-day moving average is 1045.25, which suggests ALIVUS is a Buy.
What is ALIVUS’s 50-day moving average?
ALIVUS’s 50-day moving average is 1056.73, which suggests ALIVUS is a Buy.
What is ALIVUS’s 200-day moving average?
ALIVUS’s 200-day moving average is 955.39, which suggests ALIVUS is a Buy.
What is ALIVUS’s Williams % R (14)?
ALIVUS’s Williams % R (14) is -18.10, which suggests ALIVUS is a Sell.
What is ALIVUS’s CCI (14)?
ALIVUS’s CCI (14) is 101.75, which suggests ALIVUS is a Sell.
What is the share price of Glenmark Life Sciences Limited?